MUSCLE REGENERATION
    1.
    发明申请

    公开(公告)号:US20250064792A1

    公开(公告)日:2025-02-27

    申请号:US18822966

    申请日:2024-09-03

    Abstract: The invention provides anelastase inhibitor for use in the promotion of muscle regeneration in the treatment of a myopa-thy, as well as a method for promoting muscle regeneration in a subject with a myopathy, the method comprising providing the subject with a therapeutically effective amount of an elastase inhibitor. Further provided is a pharmaceutical composition comprising anelastase inhibitor for use in the promotion of muscle regeneration in the treatment of a myopathy. Elastase inhibitors may have a protective effect on muscle progenitor cells and their regenerative potential, which aids muscle cell regeneration. By protecting regenerative potential of muscle progenitor cells, elastase inhibitors enable or enhance the grown of new or existing muscle fibres.

    COMPOSITIONS AND METHODS FOR TREATING EPILEPSY

    公开(公告)号:US20250032517A1

    公开(公告)日:2025-01-30

    申请号:US18417252

    申请日:2024-01-19

    Applicant: POVIVA CORP

    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.

    Drinking Formulation for Maintaining Urinary Tract Health in Cats

    公开(公告)号:US20250031728A1

    公开(公告)日:2025-01-30

    申请号:US18918297

    申请日:2024-10-17

    Abstract: The present disclosure relates to a liquid drinking formulation for consumption by pets, particularly cats, for preventing and/or treating urinary disorders, and stimulating water consumption. The drinking formulation comprises water that has less than 200 ppm of total minerals, and a pH between 5.9 and 7.0. Further described is a method for treating and/or preventing a urinary disorder, stimulating water consumption, and/or maintaining urinary health, in a pet, said method comprising administering the drinking formulation described herein to said pet.

    Adhesive Oral Disc For Sustained Release Of Cannabinoids

    公开(公告)号:US20250009767A1

    公开(公告)日:2025-01-09

    申请号:US18765566

    申请日:2024-07-08

    Abstract: An adhesive oral disc for sustained release of cannabinoids is presented. The disc includes one or more cannabinoids and is composed of at least a mucosal contacting layer having a mucosal contacting surface operable to be fixed to the gingiva of a person in need of alleviation or treatment of a medical condition, where the mucosal contacting layer includes one or more mucoadhesive polymers allowing the adhesive oral disc to adhere to the gingiva for an extended period of time. Further, the disc includes a non-mucoadhesive module fused to the mucosal contacting layer, where the non-mucoadhesive module includes a solid tablet composition allowing the non-mucoadhesive module to dissolve within an extended period of time upon adhesion of the adhesive oral disc to the gingiva. The invention is particularly useful for alleviation or treatment of ulcers.

Patent Agency Ranking